United States Últimas notícias

Intuitive Machines (NASDAQ:LUNR) completed in-orbit commissioning and transferred the SXM-11 satellite to SiriusXM after the geostationary communications satellite became fully operational.

Carlyle Head of Global Research & Investment Strategy Jason Thomas spoke with Bloomberg's Dani Burger from the sidelines of Carlyle's Global Investor Conference in Washington. He said the Federal Reserve is under "enormous pressure" to deliver a 25 basis-point hike. He also talked about the AI investment boom, saying an AI slowdown is "more likely than not."

Canadian Prime Minister Mark Carney says the government is expanding the scope of a major investment tax write-off to include oil and gas pipelines, mining property, and more. He made the announcement at an investment summit in Toronto.

Shengfeng Development (NASDAQ:SFWL) reported unaudited first-half 2026 revenue of approximately $311.8 million, up 18.4% year-over-year, with net income increasing to about $6.6 million.

Carlyle Global Head of Aerospace, Defense and Government Ian Fujiyama spoke with Bloomberg's Dani Burger from the sidelines of Carlyle's Global Investor Conference in Washington. He discussed the wave of investor excitement in defense tech, investing at the edge of innovation, supply-chain resilience, AI in defense, and more.

HeartSciences (NASDAQ:HSCS) reported fiscal first-quarter 2027 results with no meaningful revenue, a net loss of $3.2 million, and progress updates on its proposed business combination with Fortitude Mining Holdings.

Vera Therapeutics (NASDAQ:VERA) reported final Phase 3 ORIGIN 3 results showing TRUTAKNA (atacicept-vymj) stabilized kidney function and reduced disease progression over two years in adults with primary IgA nephropathy at risk of progression.

Lithium Argentina (NYSE:LAR) completed a $180 million strategic investment from Ganfeng through a six-year unsecured convertible note to refinance debt and extend its maturity profile.

The Buckle (NYSE:BKE) authorized a quarterly dividend of $0.35 per share following its Board of Directors meeting held on September 14, 2026.

Connect Biopharma (NASDAQ:CNTB) reported preliminary topline Phase 2 results from the Seabreeze STAT Asthma study showing rademikibart improved lung function as an add-on treatment for acute asthma exacerbations with type 2 inflammation.

Stephen Schork, principal and editor at The Schork Group, explains Iran's expanded control of Middle East oil flows and says the US strategic petroleum reserve "will be drawn down, by November, to its operational limits."

Rocket Pharmaceuticals (NASDAQ:RCKT) received alignment from the U.S. Food and Drug Administration on continued enrollment, dosing, and key design elements for its global Phase 2 pivotal trial of RP-A501 in patients with Danon disease.